Effect of Collagen Supplementation on Tendinopathy

January 14, 2021 updated by: Kasper Dideriksen, Bispebjerg Hospital

Effect of Collagen Supplementation on Tendinopathy in Elite Athletes

Tendon injuries represent a significant problem in elite athletes. Therefore, prevention and effective treatment of tendon overload injury/tendinopathy is important. Among different treatment options, heavy-slow loading based rehabilitation is considered among the most efficient treatments in athletes. In this study, we will investigate if supplementation with hydrolyzed collagen in combination with a heavy-slow loading based 12 weeks rehabilitation regime can improve treatment of tendon overload injury/tendinopathy. The investigators will examine elite athletes with overload injury/tendinopathy with regards to symptoms (pain, function), tendon morphology (ultrasonography), and vascularization (Doppler US). The investigators hypothesize that collagen supplementation can have an improving effect on tendon pain and function. Thus, the investigation will show if a rehabilitation regime of collagen supplementation combined with heavy-slow mechanical loading can improve tendon healing compared to mechanical loading alone.

Study Overview

Detailed Description

Randomized placebo-controlled intervention study with follow-up after one month

Study Type

Interventional

Enrollment (Anticipated)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Copenhagen NV, Denmark, 2400
        • Recruiting
        • Department of Physical and Occupational Therapy/Institute of Sports Medicine Copenhagen, Bispebjerg Hospital
        • Contact:
        • Principal Investigator:
          • Christian Couppé, PhD
        • Principal Investigator:
          • Kasper Dideriksen, PhD
        • Principal Investigator:
          • Christoffer Brushøj, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 38 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Elite athletes
  • 18-40 years old
  • Exercise related tendon pain on one or both legs
  • Soreness during physical examination of tendon upon palpation
  • Uni- or bilateral tendinopathy symptoms > 3 months

Exclusion Criteria:

  • Previous tendon surgery
  • Diabetes
  • Arthritis
  • Corticosteroid injection for tendinopathy within the last 3 months
  • Any form of tendon injection within the last 3 months
  • Smoking

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Collagen + heavy slow resistance group
Daily collagen supplementation + heavy slow resistance training three times weekly for 12 weeks.
Hydrolyzed collagen supplementation twice daily
Heavy slow resistance training 3 times weekly
Experimental: Placebo + heavy slow resistance group
Daily placebo supplementation + heavy slow resistance training three times weekly for 12 weeks.
Heavy slow resistance training 3 times weekly
Placebo supplementation twice daily

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maximal tendon pain during the past week at preferred sporting activity
Time Frame: Baseline-12 weeks
Change from baseline - 12 weeks using the Numerical Rating Scale (NRS; 0= no pain, 10 = worst imaginable pain)
Baseline-12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maximal tendon pain during the past week at preferred sporting activity
Time Frame: Baseline, 6 weeks + 6 month follow-up
Change from baseline - 6 weeks + 1 month follow-up using the Numerical Rating Scale (NRS; 0= no pain, 10 = worst imaginable pain)
Baseline, 6 weeks + 6 month follow-up
Self-reported activity level of sporting activities (hours/week)
Time Frame: Baseline, 6 and 12 weeks + 6 month follow-up
Participants will self-report how many hours a week they are performing sporting activities: We will monitor to see if they decrease, maintain or increase hours per week of sporting activity
Baseline, 6 and 12 weeks + 6 month follow-up
Single-leg decline squat (SLDS) test
Time Frame: Baseline - 12 weeks
A reliable patellar tendon pain provocation test, will be used to assess pain during function using the Numerical Rating Scale (NRS; 0= no pain, 10 = worst imaginable pain)
Baseline - 12 weeks
Jump test
Time Frame: Baseline - 12 weeks
A reliable Achilles/Plantaris tendon pain provocation test, will be used to assess pain during function using the Numerical Rating Scale (NRS; 0= no pain, 10 = worst imaginable pain)
Baseline - 12 weeks
Treatment satisfaction
Time Frame: 12 weeks
Participants will be asked after the intervention period whether they were satisfied or not with the treatment (dichotom : Yes vs. No)
12 weeks
Collagen supplement
Time Frame: Baseline - 12 weeks + 6 month follow-up
Participants will be asked on a weekly basis if taken their collagen supplement : Questionnaire (dichotom : Yes vs. No)
Baseline - 12 weeks + 6 month follow-up
Adverse events (e.g. allergies, gastro-intestinal side effects) related to supplement ingestion
Time Frame: Baseline - 12 weeks + 6 month follow-up
Participants will self-report adverse events during intervention period and at 6 month follow-up
Baseline - 12 weeks + 6 month follow-up
Return-to-sport activities
Time Frame: Baseline - 12 weeks + 6 month follow-up
Participants will self-report Return-to-sport activities during intervention period and at 6 month follow-up (dichotom : Yes vs. No)
Baseline - 12 weeks + 6 month follow-up
Change from baseline Victorian Institute of Sports Assessment - Patella/Achilles Questionnaire (VISA-P/A) at 12 wks
Time Frame: Baseline, 6 and 12 weeks + 6 month follow-up
Patient reported outcome regarding symptoms, function and the ability to participate in sports
Baseline, 6 and 12 weeks + 6 month follow-up
Change from baseline Foot function index - Plantaris questionnaire at 12 wks
Time Frame: Baseline, 6 and 12 weeks + 6 month follow-up
Patient reported outcome regarding symptoms, function and the ability to participate in sports
Baseline, 6 and 12 weeks + 6 month follow-up
Tendon Doppler activity using Ultrasonography power Doppler
Time Frame: Baseline - 12 weeks
Using Ultrasonography, we will measure Doppler activity within the affected tendon and use ImageJ for the analysis
Baseline - 12 weeks
Tendon thickness measured using Ultrasonography
Time Frame: Baseline - 12 weeks
Baseline - 12 weeks
Pain rating on Numeric Rating Scale (NRS; 0 = no pain; 10 = worst imaginable pain) during training.
Time Frame: Baseline, 6 and 12 weeks + 6 month follow-up
Baseline, 6 and 12 weeks + 6 month follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Director: Christian Couppé, PhD, Institute of Sports Medicine
  • Principal Investigator: Kasper Dideriksen, PhD, Team Denmark

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 16, 2020

Primary Completion (Anticipated)

January 1, 2023

Study Completion (Anticipated)

June 1, 2023

Study Registration Dates

First Submitted

September 15, 2020

First Submitted That Met QC Criteria

October 1, 2020

First Posted (Actual)

October 8, 2020

Study Record Updates

Last Update Posted (Actual)

January 19, 2021

Last Update Submitted That Met QC Criteria

January 14, 2021

Last Verified

January 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • H-16019857

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tendinopathy

Clinical Trials on Hydrolyzed collagen

3
Subscribe